Publication Name	World Journal of Diabetes
Manuscript ID	41868
Country	Croatia

Received	2018-08-29 05:30
Peer-Review Started	2018-08-29 06:01
To Make the First Decision	2018-10-17 01:52
Return for Revision	2018-10-17 06:57
Revised	2018-11-14 10:01
Second Decision	2018-11-30 08:55
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2018-12-05 18:28
Articles in Press	2018-12-05 18:28
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2019-01-10 02:02
Publish the Manuscript Online	2019-01-16 05:53

ISSN	1948-9358 (online)
Open Access	This is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Endocrinology & Metabolism
Manuscript Type	Review
Article Title	Update on biomarkers of glycemic control
Manuscript Source	Invited Manuscript
All Author List	Maja Krhač and Marijana Vučić Lovrenčić
ORCID	Author(s) ORCID Number Maja Krhač http://orcid.org/0000-0002-4510-8360 Marijana Vučić Lovrenčić http://orcid.org/0000-0001-7365-0627
Funding Agency and Grant Number
Corresponding Author	Marijana Vučić Lovrenčić, PhD, Senior Scientist, Division of Laboratory Medicine, Department of Medical Biochemistry and Laboratory Medicine, Merkur University Hospital, Zajčeva 19, Zagreb 10000, Croatia. vucic@idb.hr
Key Words	Diabetes mellitus; Hemoglobin A1c; Fructosamine; Glycated albumin; 1,5-anhydroglucitol; Plasma glucose; Glucose variability; Diabetic complications
Core Tip	Monitoring of glycemic control is currently based on the self-monitoring of blood glucose and laboratory testing for hemoglobin A1c (HbA1c), which is a surrogate marker of the average glycemia level over the past 2-3 mo. The severity of hyperglycemia and glycemic variability contribute to the pathogenesis of complications, but the HbA1c measurement reflects only a piece of these important variables. In this review, we provide a critical update on the use of HbA1c and alternative biomarkers of glycemic control, with particular emphasis on the need for a personalized approach in utilizing and interpreting different tests in a clinically meaningful manner.
Publish Date	2019-01-16 05:53
Citation	Krhač M, Vučić Lovrenčić M. Update on biomarkers of glycemic control. World J Diabetes 2019; 10(1): 1-15
URL	https://www.wjgnet.com/1948-9358/full/v10/i1/1.htm
DOI	https://dx.doi.org/10.4239/wjd.v10.i1.1

Full Article (PDF)	WJD-10-1.pdf
Full Article (Word)	WJD-10-1.docx
Manuscript File	41868-Review.docx
Answering Reviewers	41868-Answering reviewers.pdf
Audio Core Tip	41868-Audio core tip.wma
Conflict-of-Interest Disclosure Form	41868-Conflict-of-interest statement.pdf
Copyright License Agreement	41868-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	41868-Language certificate.pdf
Peer-review Report	41868-Peer-review(s).pdf
Scientific Misconduct Check	41868-Scientific misconduct check.pdf
Scientific Editor Work List	41868-Scientific editor work list.pdf